SCHEMBL3528186

SCHEMBL3528186

Cn1c(C2CC2)cc(=O)n1-c1cc(Cl)ccc1Cl

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.45
MAPT P10636 1/20 0.39
NOTUM Q6P988 2/20 0.39
ADRA1B P35368 7/20 0.37
NPSR1 Q6W5P4 2/20 0.36
TSHR P16473 1/20 0.36
HTT P42858 1/20 0.36
OPRM1 P35372 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MCOLN3 Q8TDD5 2/20 0.36
HTR1A P08908 5/20 0.36
NR1H4 Q96RI1 1/20 0.35
ADRA1A P35348 2/20 0.35
ADRA1D P25100 1/20 0.35
MEN1 O00255 1/20 0.34
MAPK1 P28482 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3532956 0.84 HSD11B1 (0.42) HSD11B1MAPTNOTUMADRA1BNPSR1
SCHEMBL3529498 0.78 DRD2 (0.42) NOTUM
SCHEMBL3528700 0.77 GRIA1 (0.35) ADRA1BHTR1AADRA1AADRA1D
SCHEMBL3535467 0.75 MEN1 (0.41) HSD11B1MAPTNOTUMALDH1A1MEN1
SCHEMBL3533770 0.75 MAPT (0.41) MAPTNPSR1TSHRALDH1A1MCOLN3
SCHEMBL3531461 0.74 HSD11B1 (0.55) HSD11B1MAPTNOTUMADRA1BNPSR1
SCHEMBL3530637 0.73 HSD11B1 (0.48) HSD11B1MAPTNOTUMADRA1BNPSR1
SCHEMBL3535358 0.72 HSD11B1 (0.38) HSD11B1ADRA1BOPRM1ALDH1A1HTR1A
SCHEMBL3527309 0.72 NPSR1 (0.36) MAPTNPSR1TSHROPRM1ALDH1A1
SCHEMBL3529348 0.71 MAPT (0.42) MAPTTSHRHTTALDH1A1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7652057-B2 Pyrazolones as 11b-HSD1 inhibitors for diabetes HOFFMAN-LA ROCHE INC. (US) 2010-01-26 US disclosed
EP-1924562-A2 PYRAZOLONE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-05-28 EP disclosed
WO-2007025880-A2 PYRAZOLONE DERIVATIVES AS 11-BETA HSD1 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2007-03-08 WO disclosed
US-20070049574-A1 New pyrazolones as 11b-HSD1 inhibitors for diabetes F. HOFFMANN-LA ROCHE AG (CH) 2007-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049574-A1 New pyrazolones as 11b-HSD1 inhibitors for diabetes HSD11B1, HSD17B1, HSD17B7 HSD11B1 1/4885MAPT 3706/4885NOTUM 1893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.